Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigensJoshua R Ehrlich, Liangdan Tang, Robert J Caiazzo, et al.
The Journal of Reproductive Medicine|June 16, 2012
Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placentaMargit Singh, David Kindelberger, Zoltan Nagymanyoki, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2016
Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cellsKuan-Chun Huang, Junzheng Yang, Michelle C Ng, et al.
Neoplasia (New York, N.Y.)|June 5, 2013
BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2Taymaa May, Junzheng Yang, Melina Shoni, et al.
Gynecologic Oncology|December 17, 2013
Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigensKatharine M Esselen, Shu-Kay Ng, Yuanyuan Hua, et al.
Gynecologic Oncology|April 26, 2011
Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placentaMargit Singh, David Kindelberger, Zoltan Nagymanyoki, et al.
Gynecologic Oncology|June 5, 2016
Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery?Katharine M Esselen, Kathryn L Terry, Anicka Samuel, et al.
Zhonghua Yi Xue Za Zhi|December 6, 2005
[Expression of topoisomerase III alpha in epithelial ovarian tumors of different types and relation between the expression of topoisomerase III alpha and the clinical pathology of tumor]Wen-ying Zhang, Ying Pan, Li-rong Zhu, et al.
Molecular Cancer Therapeutics|December 21, 2002
Relationship of XIST expression and responses of ovarian cancer to chemotherapyKuan-Chun Huang, Pulivarthi H Rao, Ching C Lau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumorsMichael V Seiden, Shu-Wing Ng, Jeffrey G Supko, et al.
Pageof 5